Proyecto de Investigación Nacionales
Contrato Miguel Servet: The role of Semaphorin4A in Rheumatoid Arthritis and Psoriatic Arthritis
Volver a proyectos01/01/2020 - 31/12/2024
Descripción
Semaphorin4A (Sema4A) is a transmembrane glycoprotein belonging to the semaphorin family, which is a large group of proteinsinitially described as axonal guidance molecules. Besides their role in controlling cell migration and axonal growth cone guidance,
further studies have shown that semaphorins regulate other biological processes relevant to pathology in RA, like the control ofimmune responses, angiogenesis, apoptosis and cell invasion. Sema4A may be one of the important molecules responsible for theelevated number of Th17 cells/cytokines observed in patients with arthritic diseases. Therefore Sema4A may be a promisingmolecular target not only for rheumatic diseases but also in other autoimmune diseases (multiple sclerosis, inflammatorybowel
disease, juvenile idiophatic arthritis, systemic sclerosis) in which Th17 cells have an essential role.
Características
| Código | CP19/00005 |
|---|---|
| Fecha de inicio | 01/01/2020 |
| Fecha de finalización | 31/12/2024 |
| Investigador responsable | Samuel García Pérez |
| Centro de realización | Hospital Álvaro Cunqueiro (Área Sanitaria de Vigo) - IIS Galicia Sur |
| Entidad financiación | Instituto de Salud Carlos III / FSE |
| Importe financiación | 242.500,00 € |
